Would a CYP2B6 test help HIV patients being treated with efavirenz?

Pharmacogenomics. 2013 Jul;14(9):999-1001. doi: 10.2217/pgs.13.69.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Benzoxazines / administration & dosage*
  • Benzoxazines / adverse effects
  • Central Nervous System / drug effects
  • Cyclopropanes
  • Cytochrome P-450 CYP2B6
  • Drug-Related Side Effects and Adverse Reactions
  • Genotype
  • HIV / drug effects
  • HIV / pathogenicity
  • HIV Infections / drug therapy*
  • HIV Infections / pathology
  • HIV Infections / virology
  • Humans
  • Polymorphism, Single Nucleotide
  • Treatment Outcome

Substances

  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • Aryl Hydrocarbon Hydroxylases
  • CYP2B6 protein, human
  • Cytochrome P-450 CYP2B6
  • efavirenz